1-2 of 2
Manuel Solano-Genesta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

Brief Report
David Gómez-Almaguer, Manuel Solano-Genesta, Luz Tarín-Arzaga, José Luis Herrera-Garza, Olga Graciela Cantú-Rodríguez, César Homero Gutiérrez-Aguirre, José Carlos Jaime-Pérez
Journal: Blood
Blood (2010) 116 (23): 4783–4785.
https://doi.org/10.1182/blood-2010-06-291831
Published: 2010
Journal Articles

Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias.

David Gomez-Almaguer, Manuel Solano-Genesta, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguilar, MD, Jose Carlos Jaime-Perez, MD, Luz Carmen Tarin-Arzaga, MD, Miguel Angel Gomez-Guijosa, MD
Journal: Blood
Blood (2009) 114 (22): 4458.
https://doi.org/10.1182/blood.V114.22.4458.4458
Published: 2009